Found: 6
Select item for more details and to access through your institution.
Glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus insulin glargine 100 U/ml in people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: the EDITION 2 randomized 12-month trial including 6-month extension
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 12, p. 1142, doi. 10.1111/dom.12532
- By:
- Publication type:
- Article
One-year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal-time insulin: the EDITION 1 12-month randomized trial, including 6-month extension.
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 9, p. 835, doi. 10.1111/dom.12472
- By:
- Publication type:
- Article
New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3).
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 4, p. 386, doi. 10.1111/dom.12438
- By:
- Publication type:
- Article
Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Comparison of clinical response to cefpirome treatment and minimum inhibitory concentration of causative isolates.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 1992, v. 29, n. suppl_A, p. 75
- By:
- Publication type:
- Article
In-vitro activity of cefpirome against isolates from patients with urinary tract, lower respiratory tract and wound infections.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 1992, v. 29, n. suppl_A, p. 7
- By:
- Publication type:
- Article